Peptisyntha SA manufactures and supplies small to commercial scale cGMP peptide APIs for pharmaceutical and biotech companies. The firm offers solid-phase peptide synthesis, liquid-phase peptide synthesis, hybrid strategies, complex peptides and peptidomimetics, peptide-conjugations, cyclic peptides and multiple disulfide bridges peptides, short peptides, and arginine-rich peptides. It serves customers worldwide. Peptisyntha was founded in 1987 and is headquartered in Brussels, Belgium.